Drug Trial Radar · NCT07606352
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Aug 4, 2026
Primary completion
Jul 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Sitala Bio LTDIndustry
- Sponsor type
- Industry
- First posted
- May 26, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo controlled Phase IIb study to explore the efficacy and safety of STL303 capsules in IgAN patients. About 15 patients dignosed with primary IgAN will be enrolled and randomized to three cohorts and take different dosage of STL303 or placebo capsules orally according to protocol.
Conditions
- IgAN
Interventions
STL303Drug
STL303 arm participants will receive a specific dose of STL303
STL303Drug
STL303 arm participants will receive a specific dose of STL303
Placebo capsuleDrug
Placebo arm participants will receive placebo capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment emergent adverse events (TEAEs), adverse events (AEs) and serious adverse events (SAEs)Time frame: Adverse events will be closely monitored, and participants will report to the clinic on Days 7, 14, 30, 45, 60, 90, 135 and at end of treatment on Day 180. On Day 210 an End of study safety follow up will also be conducted.
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
John Hunter Hospital
Newcastle, New South Wales, Australia · Recruiting
Nepean Hospital
Penrith, New South Wales, Australia · Recruiting
Prince of Wales Hospital
Sydney, New South Wales, Australia · Not yet recruiting
Concord Hospital
Sydney, New South Wales, Australia · Recruiting
Research Site
Woolloongabba, Queensland, Australia · Recruiting
Research Site
Clayton, Victoria, Australia · Recruiting
Research Site
Saint Albans, Victoria, Australia · Recruiting
Royal Perth Hospital
Perth, Western Australia, Australia · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.